3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Myelodysplastic Syndromes
5
Multiple Myeloma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Neoplasms
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Pharyngeal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Neurofibrosarcoma
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Neoplasms, Mesothelial
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Mouth Neoplasms
1
Melanoma
1
Interventions
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Recurrent
×
Sirolimus
×
30 days
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled